Motor Neurone Disease Trial, Recruiting NCT07357428 Sponsor: Paradromics Condition: Motor Neurone Disease
Back to Motor Neurone Disease

Motor Neurone Disease Trial, Recruiting

NCT07357428
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been clinically diagnosed with a progressive neuromuscular disease or a neurological injury.
  • People who have been clinically diagnosed with anarthria (complete loss of the ability to speak) or severe dysarthria (very significant difficulty speaking).
  • People who use a wheelchair and have severely limited use of their arms and hands.
  • People who have a reliable way to communicate and can read and understand English.
  • People who have a care partner (such as one or more caregivers) who is able to support them for the full duration of the study.
  • People who live within a 4-hour travel distance from a study site.

Who may not be able to join:

  • People whose cognitive difficulties or mental health conditions could make it hard to follow the study requirements, as determined by the study investigator.
  • People with other ongoing medical conditions that could make it difficult to follow the study requirements.
  • People who already have another implanted device in their body, such as a pacemaker, deep brain stimulator, or implantable pulse generator.
  • People who currently require, or are expected to require, regular MRI scans for an existing medical condition.
  • People who, in the opinion of the study investigator, would be at undue risk or otherwise unlikely to be able to comply with the study requirements for any other reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (512) 559 4120

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Paradromics
Registry
ClinicalTrials.gov
Start date
31 March 2026
Est. completion
1 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Primary Safety: Number of Subjects With Device Related Adverse Events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov